Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study

Fig. 1

Flowchart of patient selection for the final analysis and exclusion criteria. NPC nasopharyngeal carcinoma, CCD cumulative cisplatin dose, RT radiotherapy, CCRT concurrent chemoradiotherapy, NAC neoadjuvant chemotherapy, SD stable disease, PD disease progression, RECIST Response Evaluation Criteria for Solid Tumor

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us